Skip to content
    Intuitive Ventures logo

    Intuitive Ventures

    Sunnyvale, California, United StatesFounded 2020

    Intuitive Ventures is the corporate venture capital arm of Intuitive Surgical, launched in 2020 and based in Sunnyvale, California. It invests globally in early-stage companies developing innovative solutions in minimally invasive care, including precision diagnostics, focal therapeutics, digital health, and medtech.

    38% of their portfolio is in Healthcare. Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Their most common stage is series-b (41% of deals). Average disclosed round size is $76.9M (across 34 rounds with reported amounts).

    Find people at Intuitive Ventures on Goldilocks AI

    Portfolio

    24

    Fund Size

    $150M

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    Murielle Thinard McLane

    Murielle Thinard McLane

    Managing Partner and President

    Terri Burke

    Terri Burke

    Senior Partner

    Vivian Golfin (De Ruijter), MD

    Vivian Golfin (De Ruijter), MD

    Senior Associate

    Vijay Rajasekhar, MD, MBA

    Vijay Rajasekhar, MD, MBA

    Associate

    Steve Gao

    Steve Gao

    Senior Finance Manager

    Vijayalakshmi (Viji) Thyagarajan

    Vijayalakshmi (Viji) Thyagarajan

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    34 investments
    CompanyRoundAmountDate
    Flywheel logoFlywheelSeries B$27.5MDec 2025
    VAHATICOR logoVAHATICORSeries B$23MNov 2025
    SSurgical AutomationsSeed$3.4MOct 2025
    Apreo Health logoApreo HealthSeries B$130MSep 2025
    Galvanize Therapeutics logoGalvanize TherapeuticsSeries C$100MSep 2025
    OrganOx logoOrganOxGrowth$160MMay 2025
    Apreo Health logoApreo HealthSeries B$130MJan 2025
    AApreoUnknown$130MJan 2025
    Apreo Health logoApreo HealthSeries B$130MJan 2025
    CCapstan MedicalSeries C$110MDec 2024
    Capstan logoCapstanSeries C$110MDec 2024
    XII Medical logoXII MedicalSeries B$45MAug 2024
    Endogenex logoEndogenexSeries C$88MJun 2024
    Amber Therapeutics logoAmber TherapeuticsSeries A$100MJun 2024
    Neocis logoNeocisUnknown$20MJan 2024
    Amber Therapeutics logoAmber TherapeuticsSeries A$100MJan 2024
    Cellares logoCellaresSeries C$255MAug 2023
    Surge Therapeutics logoSurge TherapeuticsSeries B$32MJan 2023
    Capstan logoCapstanSeries B$175MJan 2023
    Medcrypt logoMedcryptSeries B$25MNov 2022
    Medcrypt logoMedcryptSeries B$25MNov 2022
    Optellum logoOptellumSeries A$14MSep 2022
    Galvanize Therapeutics logoGalvanize TherapeuticsSeries B$100MSep 2022
    Medcrypt logoMedcryptSeries B$25MJan 2022
    Medcrypt logoMedcryptSeries B$25MJan 2022
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026